1279 Results for: "MEDCHEMEXPRESS"

SOLUBILITY: PBS (AT PH 8.1)
LIRAGLUTIDE IS A GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONIST USED CLINICALLY TO TREAT TYPE 2 DIA BETES MELLITUS.TARGET: GLP-1 RECEPTORIN VITRO: LIRAGLUTIDE BINDS TO THE SAME RECEPTORS AS DOES THE ENDOGENOUS METABOL 1 * 1 mg

Expand 1 Items

c-Met inhibitor 1 1 * 5 mg

Supplier: MEDCHEMEXPRESS

c-Met inhibitor 1 1 * 5 mg

Expand 1 Items

Golvatinib (Synonyms: E-7050) 1 * 5 mg

Supplier: MEDCHEMEXPRESS

Golvatinib (Synonyms: E-7050) 1 * 5 mg

Expand 1 Items

LIQUID FORMAT IS 10MM1ML IN DMSO
SOLUBILITY: DMSO: ≥ 51 MG/ML
ABT-199 (GDC-0199) IS A BCL-2-SELECTIVE INHIBITOR WITH KI OF <0 .01 NM, >4800-FOLD MORE SELECTIVE VERSUS BCL-XL AND BCL-W, AND NO ACTIVITY TO MCL-1. IC50 VALUE: <0.01 NM (KI)TARGET: 1 100 mg

Supplier: MEDCHEMEXPRESS

LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ≥ 51 MG/ML
ABT-199 (GDC-0199) IS A BCL-2-SELECTIVE INHIBITOR WITH KI OF <0 .01 NM, >4800-FOLD MORE SELECTIVE VERSUS BCL-XL AND BCL-W, AND NO ACTIVITY TO MCL-1. IC50 VALUE: <0.01 NM (KI)TARGET: 1 * 100 mg

Expand 1 Items

PF-562271 1 * 1 mL

Supplier: MEDCHEMEXPRESS

PF-562271 1 * 1 mL

Expand 1 Items

LY294002 [154447-36-6] 1 * 10 mg

Supplier: MEDCHEMEXPRESS

LY294002 [154447-36-6] 1 * 10 mg

Expand 1 Items

SOLUBILITY: 10 MM IN DMSO
A939572 (SCD1 INHIBITOR) IS A POTENT, AND ORALLY BIOAVAILABLE PIPERIDINE-ARYL UREA-BASED SCD1 INHIBITOR WITH IC50 VALUES OF <4 NM AND 37 NM FOR MSCD1 AND HSCD1 RESPECTIVELY.IC50 VALUE: <4 NM (MSCD1) 37 NM (HSCD1) [1]TAR 1 * 2 mg

Supplier: MEDCHEMEXPRESS

SOLUBILITY: 10 MM IN DMSO
A939572 (SCD1 INHIBITOR) IS A POTENT, AND ORALLY BIOAVAILABLE PIPERIDINE-ARYL UREA-BASED SCD1 INHIBITOR WITH IC50 VALUES OF <4 NM AND 37 NM FOR MSCD1 AND HSCD1 RESPECTIVELY.IC50 VALUE: <4 NM (MSCD1) 37 NM (HSCD1) [1]TAR 1 * 2 mg

Expand 1 Items

PLX-4720 1 * 50 mg

Supplier: MEDCHEMEXPRESS

PLX-4720 1 * 50 mg

Expand 1 Items

RABEPRAZOLE (SODIUM) [117976-90-6] 1 * 10 mg

Supplier: MEDCHEMEXPRESS

RABEPRAZOLE (SODIUM) [117976-90-6] 1 * 10 mg

Expand 1 Items

Etoposide - 10 mM * 1 mL in DMSO 1 * 1 mL

Supplier: MEDCHEMEXPRESS

Etoposide - 10 mM * 1 mL in DMSO 1 * 1 mL

Expand 1 Items

LIQUID FORMAT IS 10MM1ML IN DMSO
SOLUBILITY: DMSO 15 MG/ML ETHANOL 5 MG/ML
ARN-509 IS A SELECTIVE AND COMPETITIVE ANDROGEN RE CEPTOR INHIBITOR WITH IC50 OF 16 NM, USEFUL FOR PROSTATE CANCER TREATMENT.IC50 VALUE: 16 NMTARGET: ANDROGEN RECEPTORA 1 50 mg

Supplier: MEDCHEMEXPRESS

LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 15 MG/ML ETHANOL 5 MG/ML
ARN-509 IS A SELECTIVE AND COMPETITIVE ANDROGEN RE CEPTOR INHIBITOR WITH IC50 OF 16 NM, USEFUL FOR PROSTATE CANCER TREATMENT.IC50 VALUE: 16 NMTARGET: ANDROGEN RECEPTORA 1 * 50 mg

Expand 1 Items

LIQUID FORMAT IS 10MM1ML IN DMSO
SOLUBILITY: DMSO 20 MG/ML (37 MM) WATER 53 MG/ML (98 MM)
NAFAMOSTAT MESYLATE, A SYNTHETIC S ERINE PROTEASE INHIBITOR, IS AN ANTICOAGULANT.TARGET: SERINE PROTEASETRANILAST (FUT-175) IS AN ANTIALLERGIC DRUG FOR 1 50 mg

Supplier: MEDCHEMEXPRESS

LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 20 MG/ML (37 MM) WATER 53 MG/ML (98 MM)
NAFAMOSTAT MESYLATE, A SYNTHETIC S ERINE PROTEASE INHIBITOR, IS AN ANTICOAGULANT.TARGET: SERINE PROTEASETRANILAST (FUT-175) IS AN ANTIALLERGIC DRUG FOR 1 * 50 mg

Expand 1 Items

SOLUBILITY: DMSO: 10 MM
MK-4101 IS A POTENT SMO INHIBITOR OF THE HEDGEHOG PATHWAY, HIGHLY ACTIVE AGAINST MEDULLOBLASTOMA AND BASA L CELL CARCINOMA.TARGET:SMOIN VIVO: MK-4101 WAS HIGHLY EFFICACIOUS AGAINST PRIMARY MEDULLOBLASTOMA AND BCC DEVELOPING 1 * 5 mg

Supplier: MEDCHEMEXPRESS

SOLUBILITY: DMSO: 10 MM
MK-4101 IS A POTENT SMO INHIBITOR OF THE HEDGEHOG PATHWAY, HIGHLY ACTIVE AGAINST MEDULLOBLASTOMA AND BASA L CELL CARCINOMA.TARGET:SMOIN VIVO: MK-4101 WAS HIGHLY EFFICACIOUS AGAINST PRIMARY MEDULLOBLASTOMA AND BCC DEVELOPING 1 * 5 mg